{"transactions":[{"id":3908581,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":166087,"kind":"person","name":"NORBY R DOUGLAS","position":1,"cik":"0001227001","reported_name":"NORBY R DOUGLAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-04T20:49:02.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on May 31, 2018 and vest monthly over a one-year period."}],"balance_after":7500,"derivative":{"exercise_price":10.29,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-18-035175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000120919118035175/doc4.xml","form_type":"4"}},{"id":3937202,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":166087,"kind":"person","name":"NORBY R DOUGLAS","position":1,"cik":"0001227001","reported_name":"NORBY R DOUGLAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-11T20:27:10.000Z","date":"2018-05-09","kind":"purchase","acquired":true,"shares":9000,"price":10.42,"value":93780.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $10.31 to $10.60. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-18-029567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000120919118029567/doc4.xml","form_type":"4"}},{"id":4323809,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":166087,"kind":"person","name":"NORBY R DOUGLAS","position":1,"cik":"0001227001","reported_name":"NORBY R DOUGLAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-05-12T18:01:36.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":2030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"RSU's will vest 100% on the 1-year anniversary of the grant date."}],"balance_after":4906,"source":{"system":"sec-edgar","filing":"0000899866-17-000112","document":"wf-form4_149462648170771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000112/wf-form4_149462648170771.xml","form_type":"4"}},{"id":4594675,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":166087,"kind":"person","name":"NORBY R DOUGLAS","position":1,"cik":"0001227001","reported_name":"NORBY R DOUGLAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-09-27T17:14:16.000Z","date":"2016-09-23","kind":"exercise","acquired":false,"shares":1774,"price":131.97,"value":234114.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.66 - $132.66.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":2876,"source":{"system":"sec-edgar","filing":"0000899866-16-000361","document":"wf-form4_147501083422588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000361/wf-form4_147501083422588.xml","form_type":"4"}},{"id":4594674,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":166087,"kind":"person","name":"NORBY R DOUGLAS","position":1,"cik":"0001227001","reported_name":"NORBY R DOUGLAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-09-27T17:14:16.000Z","date":"2016-09-23","kind":"exercise","acquired":false,"shares":3724,"price":131.1,"value":488216.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $130.56 - $131.56.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":4650,"source":{"system":"sec-edgar","filing":"0000899866-16-000361","document":"wf-form4_147501083422588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000361/wf-form4_147501083422588.xml","form_type":"4"}},{"id":4594673,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":166087,"kind":"person","name":"NORBY R DOUGLAS","position":1,"cik":"0001227001","reported_name":"NORBY R DOUGLAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-09-27T17:14:16.000Z","date":"2016-09-23","kind":"exercise","acquired":false,"shares":2800,"price":130.03,"value":364084.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $129.35 - $130.35.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":8374,"source":{"system":"sec-edgar","filing":"0000899866-16-000361","document":"wf-form4_147501083422588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000361/wf-form4_147501083422588.xml","form_type":"4"}},{"id":4594672,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":166087,"kind":"person","name":"NORBY R DOUGLAS","position":1,"cik":"0001227001","reported_name":"NORBY R DOUGLAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-09-27T17:14:16.000Z","date":"2016-09-23","kind":"exercise","acquired":false,"shares":7202,"price":128.81,"value":927689.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $128.35 - $129.35.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":11174,"source":{"system":"sec-edgar","filing":"0000899866-16-000361","document":"wf-form4_147501083422588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000361/wf-form4_147501083422588.xml","form_type":"4"}}]}